These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6839635)

  • 41. Excretion of the principal urinary metabolites of phenytoin and absolute oral bioavailability determined by use of a stable isotope in patients with epilepsy.
    Aliwarga T; Cloyd JC; Goel V; Brundage RC; Marino SE; Leppik IE; Remmel RP
    Ther Drug Monit; 2011 Feb; 33(1):56-63. PubMed ID: 21233690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of ibuprofen with the H-2 receptor antagonists ranitidine and cimetidine.
    Ochs HR; Greenblatt DJ; Matlis R; Weinbrenner J
    Clin Pharmacol Ther; 1985 Dec; 38(6):648-51. PubMed ID: 4064467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of cimetidine and ranitidine on the conversion of prednisone to prednisolone.
    Sirgo MA; Rocci ML; Ferguson RK; Eshelman FN; Vlasses PH
    Clin Pharmacol Ther; 1985 May; 37(5):534-8. PubMed ID: 3987177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers.
    Lima DR; Santos RM; Werneck E; Andrade GN
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):161-70. PubMed ID: 1814733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of cimetidine on pharmacokinetics of propranolol.
    Heagerty AM; Donovan MA; Castleden CM; Pohl JF; Patel L; Hedges A
    Br Med J (Clin Res Ed); 1981 Jun; 282(6280):1917-9. PubMed ID: 6786672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of cimetidine and ranitidine on steady-state propranolol kinetics and dynamics.
    Reimann IW; Klotz U; Frölich JC
    Clin Pharmacol Ther; 1982 Dec; 32(6):749-57. PubMed ID: 6291839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of pharmacokinetic interaction between cimetidine and pirenzepine.
    Jamali F; Mahachai V; Reilly PA; Thomson AB
    Clin Pharmacol Ther; 1985 Sep; 38(3):325-30. PubMed ID: 3839729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of 5-(4-hydroxyphenyl)-5-phenylhydantoin to the discrepancy between phenytoin analyses by EMIT and high-pressure liquid chromatography.
    Sawchuk RJ; Matzke GR
    Ther Drug Monit; 1984; 6(1):97-103. PubMed ID: 6369645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of theophylline clearance by cimetidine but not ranitidine.
    Powell JR; Rogers JF; Wargin WA; Cross RE; Eshelman FN
    Arch Intern Med; 1984 Mar; 144(3):484-6. PubMed ID: 6322709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of cimetidine on verapamil kinetics and dynamics.
    Smith MS; Benyunes MC; Bjornsson TD; Shand DG; Pritchett EL
    Clin Pharmacol Ther; 1984 Oct; 36(4):551-4. PubMed ID: 6478741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of 5-(p-hydroxyphenyl)-5-phenylhydantoin and studies relating to the disposition of phenytoin in man.
    Witkin KM; Bius DL; Teague BL; Wiese LS; Boyles LW; Dudley KH
    Ther Drug Monit; 1979; 1(1):11-34. PubMed ID: 553326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is phenytoin metabolism dose-dependent by enzyme saturation or by feedback inhibition?
    Perucca E; Makki K; Richens A
    Clin Pharmacol Ther; 1978 Jul; 24(1):46-51. PubMed ID: 657718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prolactin after repeated intravenous injections of cimetidine].
    Morosini PP; Campanella N; Pellegrini F; Pisani E; De Martinis C
    Boll Soc Ital Biol Sper; 1979 Jan; 55(1):10-3. PubMed ID: 475911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam.
    Greenblatt DJ; Locniskar A; Scavone JM; Blyden GT; Ochs HR; Harmatz JS; Shader RI
    Anesth Analg; 1986 Feb; 65(2):176-80. PubMed ID: 2935051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simultaneous determination of plasma phenytoin and its primary hydroxylated metabolites in carbon tetrachloride-intoxicated rats by high-performance liquid chromatography.
    Tanaka E; Sakamoto N; Inubushi M; Misawa S
    J Chromatogr B Biomed Appl; 1995 Nov; 673(1):147-51. PubMed ID: 8925069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenytoin metabolism during pregnancy.
    Eadie MJ; McKinnon GE; Dickinson RG; Hooper WD; Lander CM
    Eur J Clin Pharmacol; 1992; 43(4):389-92. PubMed ID: 1451718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cimetidine impairs the elimination of theophylline and antipyrine.
    Roberts RK; Grice J; Wood L; Petroff V; McGuffie C
    Gastroenterology; 1981 Jul; 81(1):19-21. PubMed ID: 7239117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenytoin metabolic ratio: a putative marker of CYP2C9 activity in vivo.
    Caraco Y; Muszkat M; Wood AJ
    Pharmacogenetics; 2001 Oct; 11(7):587-96. PubMed ID: 11668218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma concentrations of 5-(4-hydroxyphenyl)-5-phenylhydantoin in phenytoin-treated patients.
    Hoppel C; Garle M; Rane A; Sjöqvist F
    Clin Pharmacol Ther; 1977 Mar; 21(3):294-300. PubMed ID: 837648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alteration of theophylline clearance and half-life by cimetidine in normal volunteers.
    Reitberg DP; Bernhard H; Schentag JJ
    Ann Intern Med; 1981 Nov; 95(5):582-5. PubMed ID: 7294546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.